Regulation of autoreactive B cells: Checkpoints and activation

Archivum Immunologiae et Therapiae Experimentalis

Volumn 55, Issue 2, 2007, Pages 83-89

  Ding, Chuanlin ^a   Yan, Jun ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Autoreactive B cells; Infection; Tolerance; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR;

AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL INFECTION; CELL ACTIVATION; ENVIRONMENT; GENETIC SUSCEPTIBILITY; HUMAN; MOLECULAR RECOGNITION; NONHUMAN; REVIEW;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; LYMPHOCYTE ACTIVATION; MICE; TOLL-LIKE RECEPTORS;

EID: 34147132836     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-007-0011-0     Document Type: Review

References (75)

1. Bernasconi N. L., Onai N. and Lanzavecchia A. (2003): A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood, 101, 4500-4504.
2. Bernasconi N. L., Traggiai E. and Lanzavecchia A. (2002): Maintenance of serological memory by polyclonal activation of human memory B cells. Science, 298, 2199-2202.
3. Bolland S., Yim Y. S., Tus K., Wakeland E. K. and Ravetch J. V. (2002): Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. J. Exp. Med., 195, 1167-1174.
4. Busser B. W., Adair B. S., Erikson J. and Laufer T. M. (2003): Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance. J. Clin. Invest., 112, 1361-1371.
5. Christen U. and von Herrath M. G. (2004): Initiation of autoimmunity. Curr. Opin. Immunol., 16, 759-767.
6. Christensen S. R., Kashgarian M., Alexopoulou L., Flavell R. A., Akira S. and Shlomchik M. J. (2005): Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med., 202, 321-331.
7. Dale J. B. and Beachey E. H. (1985): Epitopes of streptococcal M proteins shared with cardiac myosin. J. Exp. Med., 162, 583-591.
8. Datta S. K. (2003): Major peptide autoepitopes for nucleosome-centered T and B cell interaction in human and murine lupus. Ann. NY Acad. Sci., 987, 79-90.
9. Deusch K., Fernandez-Botran R., Konstadoulakis M., Baur K., Schwartz R. S. and Madaio M. P. (1991): Autoreactive T cells from MRL-lpr/lpr mice secrete multiple lymphokines and induce the production of IgG anti-DNA antibodies. J. Autoimmun., 4, 563-576.
10. Diebold S. S., Montoya M., Unger H., Alexopoulou L., Roy P., Haswell L. E., Al-Shamkhani A., Flavell R., Borrow P. and Reis e Sousa C. (2003): Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature, 424, 324-328.
11. Ding C., Wang L., Al-Ghawi H., Marroquin J., Mamula M. and Yan J. (2006): Toll-like receptor engagement stimulates anti-snRNP autoreactive B cells for activation. Eur. J. Immunol., 36, 2013-2024.
12. Duan J. M. and Madaio M. P. (1994): Activation of a potentially pathogenic autoreactive T cell clone (ARTC-1) derived from MRL-lpr/lpr mice requires processing of self antigens. Lupus, 3, 525-526.
13. Fields M. L., Hondowicz B. D., Metzgar M. H., Nish S. A., Wharton G. N., Picca C. C., Caton A. J. and Erikson J. (2005): CD4+ CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response. J. Immunol., 175, 4255-4264.
14. Fields M. L., Nish S. A., Hondowicz B. D., Metzgar M. H., Wharton G. N., Caton A. J. and Erikson J. (2005): The influence of effector T cells and Fas ligand on lupus-associated B cells. J. Immunol., 175, 104-111.
15. Gauld S. B., Benschop R. J., Merrell K. T. and Cambier J. C. (2005): Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat. Immunol., 6, 1160-1167.
16. Gauld S. B., Merrell K. T. and Cambier J. C. (2006): Silencing of autoreactive B cells by anergy: a fresh perspective. Curr. Opin. Immunol., 18, 292-297.
17. Gay D., Saunders T., Camper S. and Weigert M. (1993): Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med., 177, 999-1008.
18. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H. and Bauer S. (2004): Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science, 303, 1526-1529.
19. Hoffman R. W., Gazitt T., Foecking M. F., Ortmann R. A., Misfeldt M., Jorgenson R., Young S. L. and Greidinger E. L. (2004): U1 RNA induces innate immunity signaling. Arthritis Rheum., 50, 2891-2896.
20. James J. A., Harley J. B. and Scofield R. H. (2001): Role of viruses in systemic lupus erythematosus and Sjogren syndrome. Curr. Opin. Rheumatol., 13, 370-376.
21. James J. A., Harley J. B. and Scofield R. H. (2006): Epstein-Barr virus and systemic lupus erythematosus. Curr. Opin. Rheumatol., 18, 462-467.
22. James J. A., Kaufman K. M., Farris A. D., Taylor-Albert E., Lehman T. J. and Harley J. B. (1997): An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest., 100, 3019-3026.
23. James J. A., Neas B. R., Moser K. L., Hall T., Bruner G. R., Sestak A. L. and Harley J. B. (2001): Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum., 44, 1122-1126.
24. Jankovic M., Casellas R., Yannoutsos N., Wardemann H. and Nussenzweig M. C. (2004): RAGs and regulation of autoantibodies. Annu. Rev. Immunol., 22, 485-501.
25. Kariko K., Ni H., Capodici J., Lamphier M. and Weissman D. (2004): mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem., 279, 12542-12550.
26. Kirvan C. A., Swedo S. E., Heuser J. S. and Cunningham M. W. (2003): Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med., 9, 914-920.
27. Krieg A. M. (1995): CpG DNA: a pathogenic factor in systemic lupus erythematosus? J. Clin. Immunol., 15, 284-292.
28. Krieg A. M., Yi A. K., Matson S., Waldschmidt T. J., Bishop G. A., Teasdale R., Koretzky G. A. and Klinman D. M. (1995): CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374, 546-549.
29. Kumar K. R., Li L., Yan M., Bhaskarabhatla M., Mobley A. B., Nguyen C., Mooney J. M., Schatzle J. D., Wakeland E. K. and Mohan C. (2006): Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science, 312, 1665-1669.
30. Lau C. M., Broughton C., Tabor A. S., Akira S., Flavell R. A., Mamula M. J., Christensen S. R., Shlomchik M. J., Viglianti G. A., Rifkin I. R. and Marshak-Rothstein A. (2005): RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med., 202, 1171-1177.
31. Leadbetter E. A., Rifkin I. R., Hohlbaum A. M., Beaudette B. C., Shlomchik M. J. and Marshak-Rothstein A. (2002): Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature, 416, 603-607.
32. Lesley R., Kelly L. M., Xu Y. and Cyster J. G. (2006): Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival. Proc. Natl. Acad. Sci. USA, 103, 10717-10722.
33. Lovgren T., Eloranta M. L., Kastner B., Wahren-Herlenius M., Alm G. V. and Ronnblom L. (2006): Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA. Arthritis Rheum., 54, 1917-1927.
34. McClain M. T., Heinlen L. D., Dennis G. J., Roebuck J., Harley J. B. and James J. A. (2005): Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat. Med., 11, 85-89.
35. McCoubrey-Hoyer A., Okarma T. B. and Holman H. R. (1984): Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus. Am. J. Med., 77, 23-34.
36. McGaha T. L., Sorrentino B. and Ravetch J. V. (2005): Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science, 307, 590-593.
37. Means T. K., Latz E., Hayashi F., Murali M. R., Golenbock D. T. and Luster A. D. (2005): Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest., 115, 407-417.
38. Medzhitov R., Preston-Hurlburt P. and Janeway C. A. Jr. (1997): A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 388, 394-397.
39. Mohan C., Adams S., Stanik V. and Datta S. K. (1993): Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med., 177, 1367-1381.
40. Morel L., Croker B. P., Blenman K. R., Mohan C., Huang G., Gilkeson G. and Wakeland E. K. (2000): Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA, 97, 6670-6675.
41. Morel L. and Wakeland E. K. (2000): Lessons from the NZM2410 model and related strains. Int. Rev. Immunol., 19, 423-446.
42. Nemazee D. A. and Burki K. (1989): Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature, 337, 562-566.
43. Nemazee D. and Buerki K. (1989): Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc. Natl. Acad. Sci. USA, 86, 8039-8043.
44. Nemazee D., Russell D., Arnold B., Haemmerling G., Allison J., Miller J. F., Morahan G. and Buerki K. (1991): Clonal deletion of autospecific B lymphocytes. Immunol. Rev., 122, 117-132.
45. Nemazee D. and Weigert M. (2000): Revising B cell receptors. J. Exp. Med., 191, 1813-1817.
46. Olson J. K., Croxford J. L., Calenoff M. A., Dal Canto M. C. and Miller S. D. (2001): A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest., 108, 311-318.
47. Patole P. S., Grone H. J., Segerer S., Ciubar R., Belemezova E., Henger A., Kretzler M., Schlondorff D.and Anders H. J. (2005): Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J. Am. Soc. Nephrol., 16, 1326-1338.
48. Paul E., Lutz J., Erikson J. and Carroll M. C. (2004): Germinal center checkpoints in B cell tolerance in 3H9 transgenic mice. Int. Immunol., 16, 377-384.
49. Pender M. P. (2003): Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol., 24, 584-588.
50. Pisitkun P., Deane J. A., Difilippantonio M. J., Tarasenko T., Satterthwaite A. B. and Bolland S. (2006): Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science, 312, 1669-1672.
51. Quinn W. J. 3rd, Noorchashm N., Crowley J. E., Reed A. J., Noorchashm H., Naji A. and Cancro M. P. (2006): Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse. J. Immunol., 176, 7159-7164.
52. Riemekasten G., Langnickel D., Ebling F. M., Karpouzas G., Kalsi J., Herberth G., Tsao B. P., Henklein P., Langer S., Burmester G. R., Radbruch A., Hiepe F. and Hahn B. H. (2003): Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies. Arthritis Rheum., 48, 475-485.
53. Rui L., Vinuesa C. G., Blasioli J. and Goodnow C. C. (2003): Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat. Immunol., 4, 594-600.
54. Ruprecht C. R. and Lanzavecchia A. (2006): Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur. J. Immunol., 36, 810-816.
55. Sainis K. and Datta S. K. (1988): CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis. J. Immunol., 140, 2215-2224.
56. Samuels J., Ng Y. S., Coupillaud C., Paget D. and Meffre E. (2005): Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med., 201, 1659-1667.
57. Savarese E., Chae O. W., Trowitzsch S., Weber G., Kastner B., Akira S., Wagner H., Schmid R. M., Bauer S. and Krug A. (2006): U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood, 107, 3229-3234.
58. Seo S. J., Fields M. L., Buckler J. L., Reed A. J., Mandik-Nayak L., Nish S. A., Noelle R. J., Turka L. A., Finkelman F. D., Caton A. J. and Erikson J. (2002): The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity, 16, 535-546.
59. Shi Y., Kaliyaperumal A., Lu L., Southwood S., Sette A., Michaels M. A. and Datta S. K. (1998): Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor alpha chain. J. Exp. Med., 187, 367-378.
60. Shores E. W., Eisenberg R. A. and Cohen P. L. (1988): TB collaboration in the in vitro anti-Sm autoantibody response of MRL/Mp-lpr/lpr mice. J. Immunol., 140, 2977-2982.
61. Singh R. R., Ebling F. M., Albuquerque D. A., Saxena V., Kumar V., Giannini E. H., Marion T. N., Finkelman F. D. and Hahn B. H. (2002): Induction of autoantibody production is limited in nonautoimmune mice. J. Immunol., 169, 587-594.
62. Soulas P., Woods A., Jaulhac B., Knapp A. M., Pasquali J. L., Martin T. and Korganow A. S. (2005): Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection. J. Clin. Invest., 115, 2257-2267.
63. Subramanian S., Tus K., Li Q. Z., Wang A., Tian X. H., Zhou J., Liang C., Bartov G., McDaniel L. D., Zhou X. J., Schultz R. A. and Wakeland E. K. (2006): A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA, 103, 9970-9975.
64. Takeda K., Kaisho T. and Akira S. (2003): Toll-like receptors. Annu. Rev. Immunol., 21, 335-376.
65. Tsuiji M., Yurasov S., Velinzon K., Thomas S., Nussenzweig M. C. and Wardemann H. (2006): A checkpoint for autoreactivity in human IgM+ memory B cell development. J. Exp. Med., 203, 393-400.
66. Viglianti G. A., Lau C. M., Hanley T. M., Miko B. A., Shlomchik M. J. and Marshak-Rothstein A. (2003): Activation of autoreactive B cells by CpG dsDNA. Immunity, 19, 837-847.
67. Vinuesa C. G. and Goodnow C. C. (2002): Immunology: DNA drives autoimmunity. Nature, 416, 595-598.
68. Vyse T. J. and Kotzin B. L. (1998): Genetic susceptibility to systemic lupus erythematosus. Annu. Rev. Immunol., 16, 261-292.
69. Wardemann H., Yurasov S., Schaefer A., Young J. W., Meffre E. and Nussenzweig M. C. (2003): Predominant autoantibody production by early human B cell precursors. Science, 301, 1374-1377.
70. William J., Euler C., Primarolo N. and Shlomchik M. J. (2006): B cell tolerance checkpoints that restrict pathways of antigen-driven differentiation. J. Immunol., 176, 2142-2151.
71. Wu X. and Peng S. L. (2006): Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum., 54, 336-342.
72. Yamanishi S., Iizumi T., Watanabe E., Shimizu M., Kamiya S., Nagata K., Kumagai Y., Fukunaga Y. and Takahashi H. (2006): Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect. Immun., 74, 248-256.
73. Yan J. and Mamula M. J. (2002): Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance. J. Immunol., 168, 3188-3194.
74. Yi A. K., Chang M., Peckham D. W., Krieg A. M. and Ashman R. F. (1998): CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J. Immunol., 160, 5898-5906.
75. Yurasov S., Wardemann H., Hammersen J., Tsuiji M., Meffre E., Pascual V. and Nussenzweig M. C. (2005): Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med., 201, 703-711.